Likewise, protein-based therapies, such as tissue plasminogen activator (tPA) for thrombolysis, have transformed emergency medicine by facilitating the breakdown of blood clots in patients with acute myocardial infarction [143,144,145,146]. This evidence concerns the gene PLAT and myocardial infarction.